Gabapentin

Sold as Neurontin, Negsez, Gabapentin MSQ, Aripentin, Gabapentin BGM, Auro-gabapentin, Binrontin, Biotech gabapentin, Epleptin, Aspen gabapentin, Epigab, Gralise, Neurexal, Gabapentin oethmaan, Gabapentin-cp

S3Read from the PI-PIL document and verified

C₉H₁₇NO₂171.24 g/mol

2-[1-(Aminomethyl)cyclohexyl]acetic acid

Drag to rotate. Structure from PubChem CID 3446.

Loading Wikipedia summary

Registration

Applicants: 15
Registrations: 48
Schedule source: SAHPRA documentation

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Viatris Healthcare (Pty) Ltd	Neurontin	100, 300, 400, 600, 800	270598, 270599, 270600, 350099, 350100	S3	PI PIL
MSQ Pharma (Pty) Ltd	Negsez	100, 300, 400	410724, 410725, 410726	S3	None
LHC Pharmaceuticals (Pty) Ltd	Gabapentin MSQ	100, 300, 400	410727, 410728, 410729	S3	None
3sixty Biopharmaceuticals (Pty) Ltd	Aripentin	100, 300, 400	430104, 430105, 430106	S3	None
BGM Pharmaceuticals (Pty) Ltd	Gabapentin BGM	100, 300, 400	430107, 430108, 430109	S3	None
Aurogen South Africa (Pty) Ltd	Auro-gabapentin, Binrontin	100 mg, 300 mg, 400 mg	430284, 430285, 430286, 430288, 430289, 430452	S3	None
Biotech Laboratories (Pty) Ltd	Biotech gabapentin	100 mg, 300 mg, 400 mg	430329, 430332, 430333	S3	None
Ranbaxy (SA) (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) LtdCancelled	Epleptin	600, 800	430597, 430598	S3	PI PIL
Pharmacare limited û woodmead	Aspen gabapentin	100 mg, 300 mg, 400 mg	430617, 430618, 430619	S3	None
Teva Pharmaceuticals (Pty) LtdCancelled	Epigab	100, 300, 400	450698, 450699, 450700	S3	None
Adcock ingram limited	Gralise	300, 600	570472, 570473	S3	PI PIL
Sandoz South Africa (Pty) LtdCancelled	Neurexal	100 mg, 300 mg, 400	A390429, A390430, A390431	S3	None
Oethmaan Biosims (Pty) Ltd	Gabapentin oethmaan	100, 300, 400	A390432, A390433, A390434	S3	None
Pharmaplan (Pty) Ltd	Gabapentin-cp	100 mg, 300 mg, 400 mg	A400024, A400025, A400026	S3	None
Ranbaxy Pharmaceutical (Pty) Ltd	Epleptin	100 mg, 300 mg, 400 mg	A400158, A400159, A400160	S3	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Neurontin 100 EACH CAPSULE CONTAINS GABAPENTIN 100 mg	100Tablets, capsules	27059827/2.5/0598Approved 7 November 2025	Registered	S3	PI PIL
Neurontin 300 EACH CAPSULE CONTAINS GABAPENTIN 300 mg	300Tablets, capsules	27059927/2.5/0599Approved 7 November 2025	Registered	S3	PI PIL
Neurontin 400 EACH CAPSULE CONTAINS GABAPENTIN 400 mg	400Tablets, capsules	27060027/2.5/0600Approved 7 November 2025	Registered	S3	PI PIL
Neurontin 600 EACH TABLET CONTAINS GABAPENTIN 600,0 mg	600Tablets, capsules	35009935/2.5/0099Approved 7 November 2025	Registered	S3	PI PIL
Neurontin 800 EACH TABLET CONTAINS GABAPENTIN 800,0 mg	800Tablets, capsules	35010035/2.5/0100Approved 7 November 2025	Registered	S3	PI PIL
Negsez 100 EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100	41072441/2.5/0724	Registered	S3	None
Negsez 300 EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300	41072541/2.5/0725	Registered	S3	None
Negsez 400 EACH CAPSULE CONTAINS GABAPENTIN 400,0 mg	400	41072641/2.5/0726	Registered	S3	None
Gabapentin 100 MSQ EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100	41072741/2.5/0727	Registered	S3	None
Gabapentin 300 MSQ EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300	41072841/2.5/0728	Registered	S3	None
Gabapentin 400 MSQ EACH CAPSULE CONTAINS: GABAPENTIN 400,0 mg	400	41072941/2.5/0729	Registered	S3	None
Aripentin 100 EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100	43010443/2.5/0104	Registered	S3	None
Aripentin 300 EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300	43010543/2.5/0105	Registered	S3	None
Aripentin 400 EACH CAPSULE CONTAINS GABAPENTIN 400,0 mg	400	43010643/2.5/0106	Registered	S3	None
Gabapentin 100 BGM EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100	43010743/2.5/0107	Registered	S3	None
Gabapentin 300 BGM EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300	43010843/2.5/0108	Registered	S3	None
Gabapentin 400 BGM EACH CAPSULE CONTAINS GABAPENTIN 400,0 mg	400	43010943/2.5/0109	Registered	S3	None
Auro-gabapentin capsules 100 MG EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100 mgCapsules	43028443/2.5/0284	Registered	S3	None
Auro-gabapentin capsules 300 MG EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300 mgCapsules	43028543/2.5/0285	Registered	S3	None
Auro-gabapentin capsules 400 MG EACH CAPSULE CONTAINS GABAPENTIN 400,0 mg	400 mgCapsules	43028643/2.5/0286	Registered	S3	None
Binrontin capsules 100 MG EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100 mgCapsules	43028843/2.5/0288	Registered	S3	None
Binrontin capsules 300 MG EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300 mgCapsules	43028943/2.5/0289	Registered	S3	None
Biotech gabapentin 300 MG EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300 mg	43032943/2.5/0329	Registered	S3	None
Biotech gabapentin 100 MG EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100 mg	43033243/2.5/0332	Registered	S3	None
Biotech gabapentin 400 MG EACH CAPSULE CONTAINS GABAPENTIN 400,0 mg	400 mg	43033343/2.5/0333	Registered	S3	None
Binrontin capsules 400 MG EACH CAPSULE CONTAINS GABAPENTIN 400,0 mg	400 mgCapsules	43045243/2.5/0452	Registered	S3	None
Epleptin 600 EACH TABLET CONTAINS GABAPENTIN 600,0 mg	600Capsule	43059743/2.5/0597Approved 9 September 2024	Cancelled	S3	PI PIL
Epleptin 800 EACH TABLET CONTAINS GABAPENTIN 800,0 mg	800Capsule	43059843/2.5/0598Approved 9 September 2024	Cancelled	S3	PI PIL
Aspen gabapentin 100 MG EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100 mg	43061743/2.5/0617	Registered	S3	None
Aspen gabapentin 300 MG EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300 mg	43061843/2.5/0618	Registered	S3	None
Aspen gabapentin 400 MG EACH CAPSULE CONTAINS GABAPENTIN 400,0 mg	400 mg	43061943/2.5/0619	Registered	S3	None
Epigab 100 EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100	45069845/2.5/0698	Cancelled	S3	None
Epigab 300 EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300	45069945/2.5/0699	Cancelled	S3	None
Epigab 400 EACH CAPSULE CONTAINS GABAPENTIN 400,0 mg	400	45070045/2.5/0700	Cancelled	S3	None
Gralise 300 Each Tablet contains: Gabapentin 300,0 mg	300Prolonged-release tablet	57047257/2.5/0472Approved 12 August 2025	Registered	S3	PI PIL
Gralise 600 Each Tablet contains: Gabapentin 600,0 mg	600Prolonged-release tablet	57047357/2.5/0473Approved 12 August 2025	Registered	S3	PI PIL
Neurexal 100 MG EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100 mg	A390429A39/2.5/0429	Cancelled	S3	None
Neurexal 300 MG EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300 mg	A390430A39/2.5/0430	Cancelled	S3	None
Neurexal 400 EACH CAPSULE CONTAINS GABAPENTIN 400,0 mg	400	A390431A39/2.5/0431	Cancelled	S3	None
Gabapentin 100 oethmaan EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100	A390432A39/2.5/0432	Registered	S3	None
Gabapentin 300 oethmaan EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300	A390433A39/2.5/0433	Registered	S3	None
Gabapentin 400 oethmaan EACH CAPSULE CONTAINS GABAPENTIN 400,0 mg	400	A390434A39/2.5/0434	Registered	S3	None
Gabapentin-cp 100 MG EACH CAPSULE CONTAINS GABAPENTIN 100,0 mg	100 mg	A400024A40/2.5/0024	Registered	S3	None
Gabapentin-cp 300 MG EACH CAPSULE CONTAINS GABAPENTIN 300,0 mg	300 mg	A400025A40/2.5/0025	Registered	S3	None
Gabapentin-cp 400 MG EACH CAPSULE CONTAINS GABAPENTIN 400,0 mg	400 mg	A400026A40/2.5/0026	Registered	S3	None
Epleptin 100 MG EACH CAPSULE CONTAINS: GABAPENTIN 100,0 mg	100 mg	A400158A40/2.5/0158	Registered	S3	None
Epleptin 300 MG EACH CAPSULE CONTAINS: GABAPENTIN 300,0 mg	300 mg	A400159A40/2.5/0159	Registered	S3	None
Epleptin 400 MG EACH CAPSULE CONTAINS: GABAPENTIN 400,0 mg	400 mg	A400160A40/2.5/0160	Registered	S3	None

Regulatory status

Where S3 sits on the scale

S0S1S2S3S4S5S6S7S8

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Gabapentin

S3: Gabapentin
Consolidated Schedules 06 July 2026, line 3659

Pharmacological class: Anticonvulsants, including anti-epileptics. (class 2.5)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Neurontin 100, Viatris Healthcare (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsNeurontin 100, Viatris Healthcare (Pty) Ltd Patient information leaflet (PIL)For patients and carersNeurontin 100, Viatris Healthcare (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background